BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6135031)

  • 1. Effect of intravenous immunoglobulin in immune thrombocytopenia.
    Salama A; Mueller-Eckhardt C; Kiefel V
    Lancet; 1983 Jul; 2(8343):193-5. PubMed ID: 6135031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
    Fehr J; Hofmann V; Kappeler U
    N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
    Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
    Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura.
    Macey MG; Macintyre EA; Newland AC
    Blut; 1986 Aug; 53(2):77-87. PubMed ID: 3730624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.
    Bussel JB
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S147-55. PubMed ID: 2477185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of idiopathic thrombocytopenic purpura and thrombocytopenia associated with the HIV virus using anti-Rhesus immunoglobulins].
    Durand JM; Lefèvre P; Lafforgue P; Harlé JR; Quinsat D; Mongin M
    Presse Med; 1989 Feb; 18(4):161-4. PubMed ID: 2522199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis due to high-dose intravenous gammaglobulin treatment for patients with idiopathic thrombocytopenic purpura.
    Nakamura S; Yoshida T; Ohtake S; Matsuda T
    Acta Haematol; 1986; 76(2-3):115-8. PubMed ID: 2433882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG.
    Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J
    Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism.
    Mueller-Eckhardt C; Salama A; Mahn I; Kiefel V; Neuzner J; Graubner M
    Scand J Haematol; 1985 May; 34(5):394-400. PubMed ID: 4012219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous gammaglobulin.
    Korninger C; Panzer S; Graninger W; Neumann E; Niessner H; Lechner K; Deutsch E
    Scand J Haematol; 1985 Feb; 34(2):128-32. PubMed ID: 3919441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura.
    Carroll RR; Noyes WD; Kitchens CS
    JAMA; 1983 Apr; 249(13):1748-50. PubMed ID: 6402619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results with the Netherlands Red Cross immunoglobulin preparation.
    Vos JJ; van Aken WG; Engelfriet CP; von dem Borne AE
    Vox Sang; 1985; 49(2):92-100. PubMed ID: 2412349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.
    Mueller-Eckhardt C; Salama A; Kiefel V; Küenzlen E; Förster C
    Blut; 1984 Jun; 48(6):353-6. PubMed ID: 6540128
    [No Abstract]   [Full Text] [Related]  

  • 15. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin.
    Smith NA; Chakraverty RK; Boughton BJ
    Clin Lab Haematol; 1990; 12(2):131-6. PubMed ID: 2119931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia.
    Salama A; Kiefel V; Mueller-Eckhardt C
    Am J Hematol; 1986 Jul; 22(3):241-50. PubMed ID: 3087158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus antibody treatment for idiopathic thrombocytopenic purpura in an Rh-negative patient.
    Rossi E; Damasio EE; Cerri R; Sogno G; Lercari G; Incagliato M; Marmont A
    Haematologica; 1988; 73(6):521-3. PubMed ID: 3148517
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of rhesus antibodies (Anti-Rh0 (D)) in autoimmune thrombocytopenia: correlation with response to high dose IgG and the degree of haemolysis.
    Panzer S; Grümayer ER; Haas OA; Niessner H; Graninger W
    Blut; 1986 Feb; 52(2):117-21. PubMed ID: 3081067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia].
    Giers G; Salama A; Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1992 Jan; 117(1):1-5. PubMed ID: 1730192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose intravenous gammaglobulin in immune haematological disease.
    Mitchell CA; Lim SG; Street AM
    Dev Biol Stand; 1987; 67():267-72. PubMed ID: 2440741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.